Cargando…

Effectiveness of Sotrovimab in the Omicron Storm Time: A Case Series

Neutralizing monoclonal antibodies (mAbs) for pre- and post-exposure prophylaxis of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) are largely used to prevent the progression of the disease by blocking viral attachment, host cell entry, and infectivity. Sotrovimab, like other available...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cicchitto, Gaetano, Cardillo, Lorena, Sequino, Davide, Sabatini, Paola, Adamo, Luisa, Marchitiello, Rosita, Viscardi, Maurizio, Cozzolino, Loredana, Cavallera, Antonietta, Bocchino, Marialuisa, Sanduzzi Zamparelli, Alessandro, Ferrigno, Francesco, de Carlo, Esterina, de Martinis, Claudio, Fusco, Giovanna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9864548/ https://www.ncbi.nlm.nih.gov/pubmed/36680143 http://dx.doi.org/10.3390/v15010102

Ejemplares similares

Effects of Casirivimab/Imdevimab Monoclonal Antibody Treatment among Vaccinated Patients Infected by SARS-CoV-2 Delta Variant
por: Cicchitto, Gaetano, et al.
Publicado: (2022)

The Evolving Concept of the Multidisciplinary Approach in the Diagnosis and Management of Interstitial Lung Diseases
por: Sanduzzi Zamparelli, Stefano, et al.
Publicado: (2023)

Correlation between clinical-functional parameters and number of lobes involved in non-cystic fibrosis bronchiectasis
por: Giacon, Valeria, et al.
Publicado: (2021)

Alpha-1-Antitrypsin Deficiency and Bronchiectasis: A Concomitance or a Real Association?
por: Sanduzzi, Alessandro, et al.
Publicado: (2020)

RP EBUS as a guide for transbronchial pulmonary biopsy in the diagnosis of organizing pneumonia
por: Cicchitto, Gaetano, et al.
Publicado: (2020)

A Phase II Study on the Effect of Taurisolo(®) Administered via AEROsol in Hospitalized Patients with Mild to Moderate COVID-19 Pneumonia: The TAEROVID-19 Study
por: Sanduzzi Zamparelli, Stefano, et al.
Publicado: (2022)

Dynapenia is highly prevalent in older patients with advanced idiopathic pulmonary fibrosis
por: Bocchino, Marialuisa, et al.
Publicado: (2021)

Sotrovimab for COVID-19
Publicado: (2021)

Sotrovimab: First Approval
por: Heo, Young-A
Publicado: (2022)

Nasopharyngeal and Oropharyngeal Swabs, And/Or Serology for SARS COVID-19: What Are We Looking For?
por: Sanduzzi, Alessandro, et al.
Publicado: (2020)

Serum KL-6 Could Represent a Reliable Indicator of Unfavourable Outcome in Patients with COVID-19 Pneumonia
por: Scotto, Riccardo, et al.
Publicado: (2021)

Liquid Biopsy Is a Promising Tool for Genetic Testing in Idiopathic Pulmonary Fibrosis
por: Pallante, Pierlorenzo, et al.
Publicado: (2021)

CORRELATIONS BETWEEN VIRAL LOAD AND SYMPTOMS IN PATIENTS WITH COVID-19 PNEUMONIA
por: CAPITELLI, L., et al.
Publicado: (2022)

Subclinical impairment of dynamic left ventricular systolic and diastolic function in patients with obstructive sleep apnea and preserved left ventricular ejection fraction
por: D’Andrea, Antonello, et al.
Publicado: (2020)

Psoriatic Disease and Tuberculosis Nowadays
por: Balato, Nicola, et al.
Publicado: (2012)

SARS-CoV-2 Serological and Biomolecular Analyses among Companion Animals in Campania Region (2020–2021)
por: Cardillo, Lorena, et al.
Publicado: (2022)

A comparative study on the persistence and viability of SARS-CoV-2 wild-type and omicron variant on artificially contaminated surfaces: the role of fomites
por: Fusco, Giovanna, et al.
Publicado: (2023)

Early treatment with sotrovimab monoclonal antibody in kidney transplant recipients with Omicron infection
por: Chavarot, Nathalie, et al.
Publicado: (2022)

Sotrovimab restores neutralization against current Omicron subvariants in patients with blood cancer
por: Wu, Mary Y., et al.
Publicado: (2023)

Body composition and obstructive sleep apnoea assessment in adult patients with Prader–Willi syndrome: a case control study
por: Pugliese, G., et al.
Publicado: (2022)

First Description of the Hyperpnea–Hypopnea Periodic Breathing in Patients with Interstitial Lung Disease-Obstructive Sleep Apnea: Treatment Implications in a Real-Life Setting
por: Canora, Angelo, et al.
Publicado: (2019)

ELDERLY PERSON WITH COVID-19 AND SEVERE ARDS WITH PROLONGED ACTIVE VIRAL REPLICATION AND DOUBLE RESURGENCE OF CYTOKINE STORM TREATED WITH SOTROVIMAB AND CASIRIVIMAB/IMDEVIMAB
por: SIRITHANAKUL, KASEM
Publicado: (2022)

A common microbial signature is present in the lower airways of interstitial lung diseases including sarcoidosis
por: D’Argenio, Valeria, et al.
Publicado: (2018)

Resistance mutations in SARS-CoV-2 omicron variant in patients treated with sotrovimab
por: Vellas, Camille, et al.
Publicado: (2022)

Sotrovimab drives SARS-CoV-2 omicron variant evolution in immunocompromised patients
por: Destras, Grégory, et al.
Publicado: (2022)

SARS-CoV-2 quantitative real time PCR and viral loads analysis among asymptomatic and symptomatic patients: an observational study on an outbreak in two nursing facilities in Campania Region (Southern Italy)
por: Cardillo, Lorena, et al.
Publicado: (2021)

Levels of circulating endothelial cells are low in idiopathic pulmonary fibrosis and are further reduced by anti-fibrotic treatments
por: De Biasi, Sara, et al.
Publicado: (2015)

Association between COVID-19 and Sick Leave for Healthcare Workers in a Large Academic Hospital in Southern Italy: An Observational Study
por: Palladino, Raffaele, et al.
Publicado: (2022)

First serological evidence of SARS-CoV-2 natural infection in small ruminants: Brief report
por: Fusco, Giovanna, et al.
Publicado: (2023)

First identification of bovine hepacivirus in wild boars
por: de Martinis, Claudio, et al.
Publicado: (2022)

Sotrovimab: Emergence of acquired resistance: 4 case reports
Publicado: (2022)

Sotrovimab-emergent resistance in SARS-CoV-2 Omicron: A series of three cases
por: Focosi, Daniele, et al.
Publicado: (2022)

Sotrovimab to prevent severe COVID-19 in high-risk patients infected with Omicron BA.2
por: Martin-Blondel, Guillaume, et al.
Publicado: (2022)

Chest CT–based Assessment of 1-year Outcomes after Moderate COVID-19 Pneumonia
por: Bocchino, Marialuisa, et al.
Publicado: (2022)

A Novel Human Neutralizing mAb Recognizes Delta, Gamma and Omicron Variants of SARS-CoV-2 and Can Be Used in Combination with Sotrovimab
por: Passariello, Margherita, et al.
Publicado: (2022)

Reactive Oxygen Species Are Required for Maintenance and Differentiation of Primary Lung Fibroblasts in Idiopathic Pulmonary Fibrosis
por: Bocchino, Marialuisa, et al.
Publicado: (2010)

Non-Invasive Assessment of Right Ventricle to Arterial Coupling for Prognosis Stratification of Fibrotic Interstitial Lung Diseases
por: Santoro, Ciro, et al.
Publicado: (2022)

Use of Sotrovimab in a Pregnant Patient With COVID-19 Infection
por: Gupta, Isha, et al.
Publicado: (2022)

Hepatocellular Carcinoma Recurrence in HCV Patients Treated with Direct Antiviral Agents
por: Sanduzzi-Zamparelli, Marco, et al.
Publicado: (2019)

Omicron’s binding to sotrovimab, casirivimab, imdevimab, CR3022, and sera from previously infected or vaccinated individuals
por: Mader, Anna-Lena, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7oacibc6ifsr541om4m3sq7tfo